相关实验视频

Updated: Sep 11, 2025

Sample Preparation for Mass-spectrometry-based Proteomics Analysis of Ocular Microvessels

Sample Preparation for Mass-spectrometry-based Proteomics Analysis of Ocular Microvessels

Published on: February 22, 2019

确定用于原发性开放角光眼的新型药物标及其由人体血蛋白质组产生的潜在副作用

Da-Dong Jia¹, Qing-Ao Xiao², Shi-Yi Song¹

¹Department of Ophthalmology, the Second People's Hospital of China Three Gorges University, the Second People's Hospital of Yichang, Yichang 443000, Hubei Province, China.

International journal of ophthalmology

|August 19, 2025

概括

这项孟德尔的随机化研究确定了四种血蛋白作为初级开放角眼镜瘤 (POAG) 的潜在治疗点. 提卡格勒勒在治疗青光瘤方面表现有前途,因为它向SVEP1,而其他向没有任何不良影响.

科学领域:

眼科医生眼科眼科
遗传学是一个遗传学.
药理学药理学是指药理学的学科.

背景情况:

主要开角光眼 (POAG) 是不可逆转失明的主要原因.
确定新的治疗点对于有效的POAG管理至关重要.
血蛋白代表了一种有希望的,但尚未被充分探索的,用于开发青光眼的药物途径.

研究的目的:

通过使用孟德尔随机化 (MR) 方法,研究血蛋白作为初级开放角光眼 (POAG) 的潜在治疗点.
确定与POAG有因果关系的特定蛋白质,并评估它们的药物向潜力.
评估已识别的蛋白质标的潜在不良影响,并探索现有的药物关联.

主要方法:

利用了大规模的蛋白质定量特征位点 (pQTLs) 和POAG全基因组关联研究 (GWAS) 数据.
采用基于总结数据的门德尔随机化 (SMR) 和依赖仪器异质性 (HEIDI) 测试.
进行了局部化,全现象MR,蛋白蛋白相互作用 (PPI) 和药物基因相互作用数据库 (DGIDb) 分析.

主要成果:

确定了四种血蛋白 (SVEP1,TMEM190,ROBO1,ENPP5) 作为潜在的POAG治疗标.
整个现象的MR表明SVEP1,ROBO1和ENPP5没有不良影响;TMEM190与神经根/神经障碍和脑下出血有关.
蒂卡格勒罗尔通过向SVEP1.1,成为一种潜在的治疗青光眼的药物.

结论:

通过MR,SVEP1,TMEM190,ROBO1和ENPP5被验证为POAG的潜在治疗标.
SVEP1,ROBO1和ENPP5为POAG药物开发提供了有利的安全概况.
蒂卡格勒洛尔在治疗青光眼的潜在用途需要进一步的研究,强调血蛋白作为可行的药物点.

关键词:

毒品目标是毒品的目标.门德尔的随机化是门德尔的随机化主要的开放角度光眼 (Glaucoma)整个蛋白质组的孟德尔随机化.

更多相关视频

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Drug Distribution: Plasma Protein Binding

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...